Utility assessment in patients with mental disorders: Validity and discriminative ability of the time trade-off method

PharmacoEconomics

Volumn 27, Issue 5, 2009, Pages 405-419

  König, Hans Helmut ^a   Günther, Oliver H ^a   Angermeyer, Matthias C ^b   Roick, Christiane ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b Center for Public Mental Health   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALCOHOLISM; ARTICLE; CLINICAL ASSESSMENT TOOL; CONSTRUCT VALIDITY; CORRELATION ANALYSIS; DEMOGRAPHY; DISCRIMINATIVE ABILITY; FEMALE; GLOBAL ASSESSMENT OF FUNCTIONING SCALE; GLOBAL ASSESSMENT OF RELATIONAL FUNCTIONING SCALE; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH OF THE NATION OUTCOME SCALE; HUMAN; INTERVIEW; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MOOD DISORDER; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; SCHIZOPHRENIA; SOCIAL AND OCCUPATIONAL FUNCTIONING SCALE; SOCIAL STATUS; TECHNIQUE; TIME TRADE OFF METHOD;

ADULT; AGED; AGED, 80 AND OVER; CHOICE BEHAVIOR; DISABILITY EVALUATION; FEMALE; HEALTH STATUS; HEALTH STATUS INDICATORS; HUMANS; LIFE EXPECTANCY; MALE; MENTAL DISORDERS; MIDDLE AGED; MODELS, ECONOMETRIC; MOOD DISORDERS; PSYCHOSES, ALCOHOLIC; QUALITY OF LIFE; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; VALUE OF LIFE;

EID: 67849116456     PISSN: 11707690     EISSN: 11792027     Source Type: Journal    
DOI: 10.2165/00019053-200927050-00005     Document Type: Article

References (56)

1. Gold M, Siegel J, Russel L, et al. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996
2. von Neumann J, Morgenstern O. Theories of games and economic behavior. Pinceton (NJ): Princeton University Press, 1947
3. Drummond MF, Sculpher MJ, Torrance GW, et al. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press, 2005
4. Macran S, Kind P. "Death" and the valuation of health-related quality of life. Med Care 2001; 39: 217-27
5. McDonough CM, Tosteson AN. Measuring preferences for cost-utility analysis: how choice of method may influence decision-making. Pharmacoeconomics 2007; 25: 93-106
6. Green C, Brazier J, Deverill M. Valuing health-related quality of life: a review of health state valuation techniques. Pharmacoeconomics 2000; 17: 151-65
7. Brazier J, Deverill M, Green C, et al. A review of the use of health status measures in economic evaluation. Health Technol Assess 1999; 3: i-iv, 1-164
8. Voruganti LN, Awad AG, Oyewumi LK, et al. Assessing health utilities in schizophrenia: a feasibility study. Pharmacoeconomics 2000; 17 (3): 273-86
9. Chisholm D, Healey A, Knapp M. QALYs and mental health care. Soc Psychiatry Psychiatr Epidemiol 1997; 32: 68-75
10. Wells KB, Sherbourne CD. Functioning and utility for current health of patients with depression or chronic medical conditions in managed, primary care practices. Arch Gen Psychiatry 1999; 56: 897-904
11. Arnesen T, Trommald M. Roughly right or precisely wrong? Systematic review of quality-of-life weights elicited with the time trade-off method. J Health Serv Res Policy 2004; 9: 43-50
12. Cronbach LJ, Meehl PE. Construct validity in psychological tests. Psychol Bull 1955; 52: 281-302
13. Roick C, Deister A, Zeichner D, et al. The regional budget for mental health care: a new approach to combine inpatient and outpatient care [in German]. Psychiatr Prax 2005; 32: 177-84
14. World Health Organization. The ICD-10 classification of mental and behavioral disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health Organization, 1992
15. The EuroQol Group. EuroQol: a new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199-208
16. The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med 1998; 28: 551-8
17. Derogatis LR. SCL-90-R: administration, scoring and procedures manual. Minneapolis (MN): National Computer Systems, 1994
18. National Institute of Mental Health. 12-CGK: Clinical Global Impressions. In: Guy W, editor. EDCEU assessment in psychopharmacology. Rockville (MD): National Institute of Mental Health, 1970: 217-22
19. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13: 261-76
20. Bech P, Bolwig TG, Kramp P, et al. The Bech-Rafaelsen Mania Scale and the Hamilton Depression Scale. Acta Psychiatr Scand 1979; 59: 420-30
21. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Press, 1994
22. Wing JK, Beevor AS, Curtis RH, et al. Health of the Nation Outcome Scales (HoNOS): research and development. Br J Psychiatry 1998; 172: 11-8
23. Torrance GW. Measurement of health state utilities for economic appraisal. J Health Econ 1986; 5: 1-30
24. Mehrez A, Gafni A. Evaluating health related quality of life: an indifference curve interpretation for the time trade-off technique. Soc Sci Med 1990; 31: 1281-3
25. Dolan P, Gudex C, Kind P, et al. The time trade-off method: results from a general population study. Health Econ 1996; 5: 141-54
26. Dolan P, Gudex C, Kind P, et al. Valuing health states: a comparison of methods. J Health Econ 1996; 15: 209-31
27. Von der Schulenburg JM, Claes C, Greiner W, et al. Die deutsche Version des Euro-Qol-Fragebogens. Zeitschrift fur Gesundheitswissenschaften 1998; 6: 3-20
28. Brooks R. EuroQol: the current state of play. Health Policy 1996; 37: 53-72
29. Konig HH, Roick C, Angermeyer MC. Validity of the EQ-5D in assessing and valuing health status in patients with schizophrenic, schizotypal or delusional disorders. Eur Psychiatry 2007; 22: 177-87
30. Gunther O, Roick C, Angermeyer MC, et al. The EQ-5D in alcohol dependent patients: relationships among health-related quality of life, psychopathology and social functioning. Drug Alcohol Depend 2007; 86: 253-64
31. Supina AL, Johnson JA, Patten SB, etal. The usefulnessof the EQ-5D in differentiating among persons with major depressive episode and anxiety. Qual Life Res 2007; 16: 749-54
32. Greiner W, Claes C, Busschbach JJ, et al. Validating the EQ-5D with time trade off for the German population. Eur J Health Econ 2005; 6: 124-30
33. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997; 35: 1095-108
34. Sapin C, Fantino B, Nowicki ML, et al. Usefulness of EQ-5D in assessing health status in primary care patients with major depressive disorder. Health Qual Life Outcomes 2004; 2: 20
35. Herrman H, Hawthorne G, Thomas R. Quality of life assessment in people living with psychosis. Soc Psychiatry Psychiatr Epidemiol 2002; 37: 510-8
36. Angermeyer MC, Kilian R, Matschinger H. WHOQOL-100 und WHOQOL-BREF: handbuch fur die deutsch-sprachige Version der WHO-Instrumente zur Erfassung von Lebensqualitat. Gottingen: Hogrefe-Verlag, 2000
37. Licht RW, Qvitzau S, Allerup P, et al. Validation of the Bech-Rafaelsen Melancholia Scale and the Hamilton Depression Scale in patients with major depression: is the total score a valid measure of illness severity? Acta Psychiatr Scand 2005; 111: 144-9
38. Cohen J. Statistical power analysis for the behavioral sciences . Hillsdale (NJ): Lawrence Earlbaum Associates, 1988
39. Konig HH. Measuring preferences of psychiatric patients [in German]. Psychiatr Prax 2004; 31: 118-27
40. Revicki DA, Kaplan RM. Relationship between psychometric and utility-based approaches to the measurement of health-related quality of life. Qual Life Res 1993; 2: 477-87
41. Lamers LM, Stalmeier PF, Krabbe PF, et al. Inconsistencies in TTO and VAS values for EQ-5D health states. Med Decis Making 2006; 26: 173-81
42. Awad AG, Voruganti LN. Impact of atypical antipsychotics on quality of life in patients with schizophrenia. CNS Drugs 2004; 18: 877-93
43. Kaiser W, Priebe S, Barr W, et al. Profiles of subjective quality of life in schizophrenic in- and out-patient samples. Psychiatry Res 1997; 66: 153-66
44. Priebe S, Oliver JPJ, Kaiser W. Quality of life and mental health care. Petersfield: Wrightson Biomedical, 1999
45. Corrigan PW, Buican B. The construct validity of subjective quality of life for the severely mentally ill. J Nerv Ment Dis 1995; 183: 281-5
46. Katschnig H. Schizophrenia and quality of life. Acta Psychiatr Scand Suppl. 2000; 407: 33-7
47. Franz M, Meyer T, Reber T, et al. The importance of social comparisons for high levels of subjective quality of life in chronic schizophrenic patients. Qual Life Res 2000; 9: 481-9
48. Tsevat J, Sherman SN, McElwee JA, et al. The will to live among HIV-infected patients. Ann Intern Med 1999; 131: 194-8
49. Perez DJ, McGee R, Campbell AV, et al. A comparison of time trade-off and quality of life measures in patients with advanced cancer. Qual Life Res 1997; 6: 133-8
50. Fryback DG, Dasbach EJ, Klein R, et al. The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors. Med Decis Making 1993; 13: 89-102
51. Dolan P. Whose preferences count? Med Decis Making 1999; 19: 482-6
52. Boyd NF, Sutherland HJ, Heasman KZ, et al. Whose utilities for decision analysis? Med Decis Making 1990; 10: 58-67
53. Kassirer JP. Incorporating patients' preferences into medical decisions. N Engl J Med 1994; 330: 1895-6
54. Weinstein MC, Siegel JE, Gold MR, et al. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA 1996; 276: 1253-8
55. Gunther OH, Roick C, Angermeyer MC, et al. The responsiveness of EQ-5D utility scores in patients with depression: a comparison with instruments measuring quality of life, psychopathology and social functioning. J Affect Disord 2008; 105: 81-91
56. Angell M. Patients' preferences in randomized clinical trials. N Engl J Med 1984; 310: 1385-7